Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach cramps are one of the most commonly reported side effects of Mounjaro (tirzepatide), and they tend to peak in the first few days after starting or after a dose increase. For most people they are temporary, mild to moderate, and ease within a week or two as the body adjusts. Mounjaro is a prescription-only medicine assessed and prescribed by a clinician; whether it is right for you depends on your full medical picture, not just your BMI. The NHS patient information for tirzepatide confirms that gastrointestinal symptoms are among the most frequent side effects of tirzepatide, and the guidance below will help you understand what to expect, what to do, and when to act fast.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) that work together to reduce appetite and regulate blood sugar. A key part of how it does this is by slowing gastric emptying: food sits in the stomach longer, digestion moves at a different pace, and the intestine has to adapt. That mechanical shift is the root cause of most stomach cramps. The gut muscles, which normally work in a fairly predictable rhythm, are suddenly working against a slower food transit, and that can trigger spasm and cramping sensations anywhere from the upper abdomen down to the lower gut. You can read more about the GIP receptor mechanism in tirzepatide and why the dual-agonist approach differs from older single-pathway medicines.
The timing matters. Cramps tend to arrive in the 12–48 hours after each weekly injection, when the medicine's concentration is rising in your system. They are often worse after dose increases, which is why the standard schedule moves slowly, 2.5 mg is a starting point chosen for tolerability, not a therapeutic target. Plenty of people get through the early doses with only mild discomfort and find cramps become largely background noise by the time they reach mid-range doses. Others find each step up brings a fresh wave of symptoms. Both patterns are documented. For a fuller picture of how stomach cramps from Mounjaro typically progress, the pattern sections there go into more detail on what changes dose by dose.
Dehydration makes everything worse. When nausea and cramping reduce your appetite, it is easy to drink less too, and even mild dehydration amplifies gut discomfort. Small, frequent sips throughout the day, especially in the 24 hours post-injection, are more useful than trying to compensate with a large glass of water all at once.
Most Mounjaro-related cramping is diffuse, comes and goes in waves, and is clearly linked to eating or to the post-injection window. It is uncomfortable but manageable. Ordinary adjustment cramps do not usually stop you functioning, and they do not worsen over several days, they plateau and then ease.
The cramps worth paying attention to are a different character entirely. If the pain is severe and does not let up, if it spreads to your back or shoulder, or if it arrives alongside vomiting you cannot control, that is not a typical adjustment symptom. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis as a known but infrequent risk: the symptom pattern is a sudden, intense abdominal pain that may radiate into the back, sometimes with vomiting. That needs same-day medical attention. Do not wait for your next prescription review.
Gallbladder symptoms are another category to keep in mind. GLP-1-based medicines are associated with a small increased risk of gallstones and related problems, and biliary colic can feel superficially similar to bad stomach cramps, but tends to be more localised (upper right abdomen), sharp, and triggered by fatty meals. Again, if you are unsure, seek medical advice rather than attributing the pain to routine Mounjaro adjustment. The tirzepatide overview page covers the broader side-effect profile if you want the full picture alongside cramps.
Menstrual cramps are worth a separate note. Some people find their cycle changes in the early months of treatment (weight and hormone-sensitive conditions do interact) and it can be genuinely difficult to tell period pain from gut cramping when both arrive at once. There is dedicated guidance on Mounjaro and period cramps that separates the two and offers practical context.
The evidence base for managing GLP-1 gut side effects is mostly practical rather than pharmacological. Small, frequent meals beat large ones. High-fat foods slow gastric emptying further, so if Mounjaro is already doing that job, a burger and chips on injection evening is likely to make cramping noticeably worse. Plain, easily digested foods in the 24 hours around your injection can make a real difference. Fizzy drinks and alcohol both increase gut gas and irritation; cutting them temporarily around injection day is sensible.
Some people find a heat pad on the lower abdomen helpful for cramping, the mechanical relief from warmth on smooth muscle is well established for gut spasm generally, and there is no reason it would not apply here. Peppermint-based products (tea or capsules) have some evidence for gut spasm reduction and are generally safe alongside tirzepatide, but check with your prescriber if you take other medicines.
Leg cramps occasionally come up separately from abdominal cramping (likely a different mechanism, probably linked to electrolyte shifts and reduced intake) and Mounjaro and leg cramps addresses that specifically. Worth bookmarking if you are experiencing both.
If cramps are consistently severe enough to disrupt your day, that is a clinical conversation, not a gritting-your-teeth situation. Your prescriber can discuss whether slowing the titration, staying longer at your current dose, or other adjustments are appropriate. The cost of treatment (and the context behind the Eli Lilly UK price increase that affected many patients in late 2025) is a real factor for people weighing whether to continue, so understanding the full picture of private prescribing matters too.
Cramps that are new, severe, or different in character from your usual post-injection discomfort: contact someone the same day. Severe upper or central abdominal pain that radiates to the back: this is the pancreatitis warning sign noted in the MHRA's safety communication, and it needs urgent assessment, call 111 or go to A&E rather than waiting for a GP appointment. Signs of dehydration from persistent vomiting alongside cramping (dizziness, very dark urine, inability to keep fluids down): these also need prompt medical contact because kidney function can be affected by significant fluid loss.
For people managing treatment through a regulated online pharmacy, urgent queries do not have to wait until Monday. At our pharmacy, aftercare support runs seven days a week precisely because side effects do not keep office hours. If you are concerned and currently on treatment with us, contact our clinical team directly rather than searching for answers on a forum.
Mounjaro arrives through the post in plain, unbranded packaging via DPD (most patients get a tracking notification the morning it is on the way) and each KwikPen contains four weekly doses to refrigerate at home. The pen itself is relatively compact and straightforward to use, but good injection technique (rotating sites, injecting at the right depth) can also reduce localised post-injection discomfort that sometimes gets muddled with gut cramping. Your Patient Information Leaflet covers technique; the general FAQs pick up common questions beyond what the leaflet addresses.
If you are not yet on treatment and are wondering whether Mounjaro is appropriate for you, the right starting point is a clinical assessment. Check your eligibility and start a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.